ECTRIMS 2024 Insights: Autologous Hematopoietic Stem Cell Transplantation vs Alemtuzumab in Multiple Sclerosis: An Italian Multicenter Study
92 views
September 27, 2024
Comments 0
Login to view comments.
Click here to Login